SPY312.23+1.71 0.55%
DIA258.42+1.11 0.43%
IXIC10,207.63+53.00 0.52%

PiperJaffray Reiterates Overweight on Adverum Biotechnologies, Raises Price Target to $20

PiperJaffray analyst Tyler Van Buren reiterates Adverum Biotechnologies (NASDAQ:ADVM) with a Overweight and raises the price target from $14 to $20.

Benzinga · -

PiperJaffray analyst Tyler Van Buren reiterates Adverum Biotechnologies (NASDAQ:ADVM) with a Overweight and raises the price target from $14 to $20.